The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

The Swedish Cancer Society’s Planning Group for Oncological Radionuclide Therapy 2026

The 2026 annual meeting of The Swedish Cancer Society’s Planning Group for Oncological Radionuclide Therapy will take place at Elite Hotel Ideon in Lund November 26-27. Additionally, a half-day course on the topic clinical trials is planned for the afternoon November 25.

Lund University main building on a foggy night
Foto: Mikael Risedal

N.B. The usual home page, "radionuklidterapi.se", is currently undergoing reconstruction. This web address will only be used for 2026.

Registration

The deadline for registration is September 28. 

Participants

Registration is free of charge for participants. Registration has been closed. Please contact johan_ruben [dot] gustafsson [at] med [dot] lu [dot] se (johan_ruben[dot]gustafsson[at]med[dot]lu[dot]se) for inquiries about late registration.

Note that a separate registration is required for the half-day course November 25 (see below).

Sponsors 

We welcome you as sponsor, according to our prior agreement. Registration has been closed. Please contact johan_ruben [dot] gustafsson [at] med [dot] lu [dot] se (johan_ruben[dot]gustafsson[at]med[dot]lu[dot]se) for inquiries about late registration.

Abstract submission

Abstracts covering any aspect of oncological radionuclide therapy are welcome, including radiopharmaceutical development, pre-clinical and clinical applications, physics and technical aspects. The deadline for abstract submission is October 16 and notification of acceptance will be sent by e-mail to authors by November 9.

Please submit your abstract through this link. This link also contains detailed information about abstract format. A template for Word can be found below. 

Meeting programme

The full program will appear here before the meeting. The meeting will start November 26 at 9:00 and end by November 27 at 13:00 (approximately). A dinner is also planned for the evening on Thursday November 26 

Venue(s)

The conference will take place at Elite Hotel Ideon in Lund. Link to map

The educational half-day will take place at Torsten-Landberg-salen at the Radiotherapy department, Skåne University Hospital, Lund. Link to map.

Accomodation

Elite Ideon hotel has kindly arranged for a special offer for this meeting. For hotel reservation follow this link: Radionulkidterapi2026

Seminar on clinical trials

Preceding the meeting, the afternoon November 25 is planned for a mini course on the topic clinical trials. The seminar will broadly cover the regulatory background and basic aspects to consider for designing, planning and undertaking a clinical trial. All participants are welcome to attend. 

Please register for the seminar using this link by October 16 at the latest.

Seminar programme
TitleSpeaker
Regulatory Affairs: From experience-based medicine to evidence-based researchAnna Sundlöv, MD, PhD, Specialist in Oncology, Senior Clinical Assessor, Clinical Trials and Special Permissions, Swedish Medical Products Agency
Clinical trials - my personal experienceMats Jerkeman, Professor, Medical oncology, Senior Consultant, Lund university, Region Skåne, Lund university cancer center (LUCC)
Planning and conducting clinical studies: From idea to resultsAnn-Sofi Svensson, Senior Project Manager, Center Clinical Research, Skåne University Hospital, Lund
From target to trial: The development and clinical translation of 177Lu-AKIR001Marika Nestor, Professor, Biomedical Radiation Sciences, Department of Immunology, Genetics and Pathology, Uppsala University and CEO and Co-Founder of Akiram Therapeutics

Contact

johan_ruben [dot] gustafsson [at] med [dot] lu [dot] se

We gratefully acknowledge the generous support  

Logotypes for Cancerfonden, Lunds universitet, and Region Skåne
Företagslogoyper 1 CF 2026
Ridgeview, Mediso, Tetrakit
Atley